Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks detectable expression of estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and progesterone receptor (PR). This evidence concerns the gene PGR and breast carcinoma.